ascopubs.org

Implementation of Real-World Diagnostic Strategies in Taiwan for the Identification of Targetable Oncogenic Driver Alterations in Non–Small Cell Lung Cancer

EGFR G719X 2 (1.3) No additional alterations detected (including one QC for RNAl) 2 EGFR L861Q 4 (2.7) No additional alterations detected 4 DNA and RNA were extracted from formalin-fixed ...
Cure Today

Biomarker Testing Remains Crucial for Young Patients With Lung Cancer

Young lung cancer patients have a higher incidence of targetable biomarkers, necessitating comprehensive testing for ALK fusions and EGFR mutations. Repeat biomarker testing is essential when ...
ascopubs.org

NGS testing for patient selection in left-sided RAS/BRAF wild-type metastatic colorectal cancer receiving anti-EGFR therapy.

Clinical value of carbon nanoparticle staining in identifying metastatic lymph nodes in colorectal cancer surgery. PFS in anti-EGFR therapy depending on gene alteration.
Fred Hutch

Targeted Therapy for Lung Cancer

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...